Exelixis Inc (EXEL)
21.90
-0.22
(-0.99%)
USD |
NASDAQ |
May 03, 16:00
21.90
0.00 (0.00%)
After-Hours: 20:00
Exelixis Cash from Operations (Quarterly): 68.82M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 68.82M |
| December 31, 2023 | 10.57M |
| September 30, 2023 | 117.37M |
| June 30, 2023 | 120.98M |
| March 31, 2023 | 84.41M |
| December 31, 2022 | 73.69M |
| September 30, 2022 | 110.07M |
| June 30, 2022 | 31.13M |
| March 31, 2022 | 147.72M |
| December 31, 2021 | 96.45M |
| September 30, 2021 | 83.31M |
| June 30, 2021 | 181.50M |
| March 31, 2021 | 39.54M |
| December 31, 2020 | 33.29M |
| September 30, 2020 | 17.94M |
| June 30, 2020 | 101.68M |
| March 31, 2020 | 56.07M |
| December 31, 2019 | 158.02M |
| September 30, 2019 | 75.61M |
| June 30, 2019 | 131.73M |
| March 31, 2019 | 161.59M |
| December 31, 2018 | 104.59M |
| September 30, 2018 | 164.86M |
| June 30, 2018 | 74.46M |
| March 31, 2018 | 71.81M |
| Date | Value |
|---|---|
| December 31, 2017 | 53.35M |
| September 30, 2017 | 37.86M |
| June 30, 2017 | 5.535M |
| March 31, 2017 | 68.86M |
| December 31, 2016 | 85.11M |
| September 30, 2016 | -5.781M |
| June 30, 2016 | -25.73M |
| March 31, 2016 | 156.81M |
| December 31, 2015 | -34.90M |
| September 30, 2015 | -34.23M |
| June 30, 2015 | -26.83M |
| March 31, 2015 | -45.09M |
| December 31, 2014 | -49.98M |
| September 30, 2014 | -58.01M |
| June 30, 2014 | -55.34M |
| March 31, 2014 | -72.09M |
| December 31, 2013 | -47.33M |
| September 30, 2013 | -57.00M |
| June 30, 2013 | -40.03M |
| March 31, 2013 | -54.42M |
| December 31, 2012 | -38.74M |
| September 30, 2012 | -34.05M |
| June 30, 2012 | -35.39M |
| March 31, 2012 | -14.97M |
| December 31, 2011 | -29.17M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
10.57M
Minimum
Dec 2023
181.50M
Maximum
Jun 2021
87.00M
Average
83.86M
Median
Cash from Operations (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 1.090B |
| Johnson & Johnson | 3.657B |
| Merck & Co Inc | 246.00M |
| Pfizer Inc | 5.24B |
| Legend Biotech Corp | -95.64M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 111.79M |
| Cash from Financing (Quarterly) | -184.05M |
| Free Cash Flow | 185.10M |
| Free Cash Flow Per Share (Quarterly) | 0.1657 |
| Free Cash Flow to Equity (Quarterly) | 50.63M |
| Free Cash Flow to Firm (Quarterly) | 50.63M |
| Free Cash Flow Yield | 2.67% |